Back

Tumor-driven cytokines IL-13 and IFN-γ ameliorate pressure overload–induced cardiac dysfunction

31 August 2026 (13:15 - 14:00)
Organised by: Logo
Congress Presentation Part of: Phenotypic approaches to heart failure treatment Experimental Heart Failure ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Ms Lama Awwad

Technion - Israel Institute of Technology, Haifa (Israel)

6 More presentations in this session

Presentation thumbnail
Investigating the role of neutrophils in trametinib-induced cardiomyopathy
Doctor S. Morrissey (Chapel Hill, US)
Abstract Slides Video
Presentation thumbnail
Influence of invasive ischemic evaluation on mortality in patients with a new onset heart failure after myocardial infarction
Doctor M. Ferreira (Funchal, PT)
Abstract Slides Video
Presentation thumbnail
Effects of empagliflozin according to background angiotensin receptor-neprilysin inhibitor and mineralocorticoid receptor antagonist use in heart failure with reduced ejection fraction (SUGAR-DM-HF)
Doctor M. Lee (Glasgow, GB)
Abstract Slides Video
Presentation thumbnail
The sugar alcohol sweeteners Erythritol and Xylitol are linked with heart failure
Doctor M. Witkowski (Berlin, DE)
Presentation thumbnail
Somatic DNMT3A and TET2 mutations in explanted hearts from advanced heart failure show enrichment in myocarditis and inflammatory heart disease
Mrs S. Ramanathan (Gothenburg, SE)
Abstract Slides Video

Access the full session

Session thumbnail
Phenotypic approaches to heart failure treatment

The Event

Event poster

ESC Congress 2026

31 August 2026 13:15 CET
You may be interested in
thumbnail
Congress Session
Young Investigator Award (YIA) Basic Science
11 May 2024
thumbnail
Congress Presentation
Cytokines as potential novel therapy targets in inflammatory cardiomyopathy
30 August 2026
thumbnail
Congress Presentation
Accelerated adverse cardiac remodeling in a model of TET2 mutation-driven clonal hematopoiesis is ameliorated by IFNa treatment by modulating the monocyte response
20 June 2025
thumbnail
Congress Presentation
Enhancing heart regeneration and repair after myocardial infarction through inhibition of a specific MicroRNA by targeting the IFNy-JAK-STAT pathway.
30 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources